ARM Stock: Buy or Sell? Price Target & Forecast

Analyses / ARM

ARM Arm Holdings PLC As of Sep 15, 2026

$239.01

Down 41% from 52-week high; extreme valuations and insider selling offset long-term AI licensing tailwinds.

Setup: Recovery / Risk-Off Correction Confidence: 55 Horizon: 3-6 months Risk: High Category: Growth / Semiconductor

🔒 Trade Plan — entry · target · stop

Entry Zone

$•••–•••

Target

$•••

Stop Loss

$•••

Risk / Reward

•.• : 1

Unlock the exact levels — free →

A free account reveals ARM's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.

The Thesis

▲ Bull Case

Arm licenses IP to nearly every AI chip designer (NVIDIA, AMD, QCOM, etc.); 22% revenue growth, 97% gross margins, fortress balance sheet (5.99x current ratio). AI-driven compute expansion across data centers, mobile, edge creates structural licensing demand. Stock has fallen 47% from peak — potential value trap setup if market regains risk appetite.

▼ Bear Case

Valuation remains extreme: P/E 260x, P/S 55x, Price-to-FCF 286x despite correction. Forward P/E 300x suggests market pricing perfection. Insider selling (68 sells vs 49 buys) and broader semiconductor pullback signal caution. Binary regulatory risks (Huawei sanctions, China trade policy). Near-term margin of safety limited.

Valuation

SEVERELY OVERVALUED (even after 47% pullback) — score 18/100

All multiples in top decile of S&P 500: P/E 260x, P/S 55x, EV/EBITDA 269x, Price-to-FCF 286x. 22% revenue & 18% EPS growth do not justify these premia. Stock has compressed from $453 to $239; valuation risk remains acute.

Technical Levels

Support · $210.00 (Psychological support; 15% below current) · $185.00 (Likely buy-point if broader chip selloff deepens) · $100.00 (52-week low; extreme capitulation scenario)

Resistance · $265.00 (Prior close resistance) · $290.00 (Round-number supply; consolidation zone) · $350.00 (Bull target; would require valuation re-rating) · $453.00 (52-week high; structural overhead)

RSI: Unknown (data unavailable from provider).

Financial Health

Score 85/100. Arm has fortress liquidity and minimal working-capital needs (IP licensing model). No debt detail provided, but high current/quick ratios + 97% gross margin suggest net-cash or low-leverage position. Financial risk is low; operational/valuation risk is high.

Catalysts

Q2/Q3 2024 Earnings	Next 2–3 months (typical semiconductor reporting window)	HIGH — Guidance on AI licensing growth & customer mix (Huawei exposure) will reset valuation expectations.
China Trade Policy / Huawei Sanctions Update	Ongoing, binary	HIGH — Regulatory headwinds could cut revenue by 10–20% if Huawei restricted.
AI Capex Cycle Confirmation or Slowdown	Q4 2024 – Q1 2025 (customer guidance season)	HIGH — If NVIDIA, AMD, QCOM capex budgets decline, Arm licensing demand may soften.
Insider Buying Surge	Watch for reversal in insider activity (currently net-neutral)	MEDIUM — Reversal to net buys would signal management confidence.

Risk Flags

Valuation metrics extreme across all multiples (P/E 260x, P/S 55x); any miss could trigger re-rating.

Insider selling pressure (68 sells vs 49 buys, net neutral on shares) suggests insiders cautious near highs.

Beta 3.85x = high correlation to risk-off moves; semiconductor sector selloff is ongoing.

No dividend; all returns depend on capital appreciation.

China trade policy and Huawei restrictions create binary geopolitical risk to revenue.

EV/EBITDA 269x and Price-to-FCF 286x imply zero margin for error on growth forecasts.

See ARM's full trade plan — free

Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.

Unlock ARM free →

More Analyses

NVDA

AAPL

TSLA

MSFT

AMZN

GOOGL

ARM FAQ

Is ARM a buy right now?

Arm Holdings PLC's current read is a Recovery / Risk-Off Correction setup with 55 confidence over a 3-6 months horizon. Valuation: SEVERELY OVERVALUED (even after 47% pullback). See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.

Is ARM overvalued?

SEVERELY OVERVALUED (even after 47% pullback) (valuation score 18/100). All multiples in top decile of S&P 500: P/E 260x, P/S 55x, EV/EBITDA 269x, Price-to-FCF 286x. 22% revenue & 18% EPS growth do not justify these premia. Stock has compressed from $453 to $239; valuation risk remains acute.

What are the risks of buying ARM?